Nexpoint Asset Management’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Nexpoint Asset Management’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-265,794	Closed	-$8.98M	–	239
2021 Q2	$8.98M	Buy	+265,794	New	+$6.77M	1.96%	16

Nexpoint Asset Management's CNST Position: Q3 2021 in Review

Nexpoint Asset Management sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 265,794 shares — an estimated $8.98M sold.

Nexpoint Asset Management first reported a position in CNST in Q2 2021 and held it in 1 quarter. The position peaked at $8.98M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

Nexpoint Asset Management reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Nexpoint Asset Management sold 265,794 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $8.98M.
Nexpoint Asset Management first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2021 and held it in 1 quarter.
Nexpoint Asset Management's Constellation Pharmaceuticals, Inc. position peaked at $8.98M in Q2 2021.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Nexpoint Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.